Induced pluripotent reprogramming from promiscuous human sternness-related factors

Clinical and Translational Science

Volumn 2, Issue 2, 2009, Pages 118-126

  Nelson, Timothy J ^a   Martinez Fernandez, Almudena ^a   Yamada, Satsuki ^a   Mael, Amber A ^b   Terzic, Andre ^a   Ikeda, Yasuhiro ^b  

^a Marriott Heart Disease Research Program   (United States)

^b MAYO CLINIC   (United States)

Author keywords

c MYC; Chimera; HIV; iPS; KLF4; Lentiviral; OCT3 4; Ortholog; SOX2

Indexed keywords

KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLASTOMERE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GASTRULATION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC CONSERVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MORULA; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; SPECIES DIFFERENCE; TERATOMA; ANIMAL; BLASTOCYST; CELL LINE; CELL LINEAGE; CYTOLOGY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; METABOLISM; MUTATION; ORGANOGENESIS; PEDIGREE; VIRUS ASSEMBLY; VIRUS CAPSID;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IPS; MIRIDAE;

ANIMALS; BLASTOCYST; CAPSID; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELLULAR REPROGRAMMING; FEMALE; FIBROBLASTS; GASTRULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; HIV; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MUTATION; ORGANOGENESIS; PEDIGREE; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY;

EID: 70349706450     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2009.00091.x     Document Type: Article

References (54)

1. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385(6691): 810-813.
2. Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature. 1996; 380(6569): 64-66.
3. Hochedlinger K, Jaenisch R. Nuclear reprogramming and pluripotency. Nature. 2006; 441(7097): 1061-1067.
4. Armstrong L, Lako M, Dean W, Stojkovic M. Epigenetic modification is central to genome reprogramming in somatic cell nuclear transfer. Stem Cells. 2006; 24(4): 805-814.
5. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature. 2007; 450(7169): 497-502.
6. Beyhan Z, Iager AE, Cibelli JB. Interspecies nuclear transfer: implications for embryonic stem cell biology. Cell Stem Cell. 2007; 1(5): 502-512.
7. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008; 132(4): 567-582.
8. Henderson JT. Lazarus's gate: Challenges and potential of epigenetic reprogramming of somatic cells. Clin Pharmacol Ther. 2008; 83(6): 889-893.
9. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-676.
10. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448 (7151): 313-317.
11. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5) 861-872.
12. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 2007; 25(10): 1177-1181.
13. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007; 1(1): 55-70.
14. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858) 1917-1920.
15. Yamanaka S. Pluripotency and nuclear reprogramming. Phil Trans R Soc B. 2008; 363 (1500) 2079-2087.
16. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151): 318-324.
17. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008; 451(7151): 141-146.
18. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5): 877-886.
19. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science. 2008; 322(5903): 945-949.
20. Liu H, Zhu F, Yong J, Zhang P, Hou P, Li H, Jiang W, Cai J, Liu M, Cui K, Qu X, Xiang T, Lu D, Chi X, Gao G, Ji W, Ding M, Deng H. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell. 2008; 3(6): 587-590.
21. Koonin EV. Orthologs, paralogs, and evolutionary genomics. Annu Rev Genet. 2005; 39 309-338.
22. Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 2007; 128(4): 747-762.
23. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006; 38(4): 431-440.
24. Daheron L, Opitz SL, Zaehres H, Lensch MW, Andrews PW, Itskovitz-Eldor J, Daley GQ. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells. 2004; 22(5): 770-778.
25. Xu C, Rosier E, Jiang J, Lebkowski JS, Gold JD, O'Sullivan C, Delavan-Boorsma K, Mok M, Bronstein A, Carpenter MK. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells. 2005; 23(3): 315-323.
26. Ikeda Y, Collins MK, Radcliffe PA, Mitrophanous KA, Takeuchi Y. Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther. 2002; 9 (14): 932-938.
27. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell. 2008; 2(3): 230-240.
28. Mali P, Ye Z, Hommond HH, Yu X, Lin J, Chen G, Zou J, Cheng L. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 2008; 26(8): 1998-2005.
29. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997; 15(9): 871-875.
30. Ikeda Y, Ylinen LM, Kahar-Bador M, Towers GJ. Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J Virol. 2004; 78(21): 11816-11822.
31. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci USA. 2003; 100(3) 1298-1303.
32. Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, Grez M, Thrasher AJ. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency]virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther. 2002; 13(7): 803-813.
33. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEBJ. 2002; 16(12): 1558-1566.
34. Perez-Terzic C, Behfar A, Mery A, van Deursen JM, Terzic A, Puceat M. Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes. Circ Res. 2003: 92(4): 444-452.
35. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med. 2007; 204(2): 405-420.
36. Faustino RS, Behfar A, Perez-Terzic C, Terzic A. Genomic chart guiding embryonic stem cell cardiopoiesis. Genome Biol. 2008: 9: R6.
37. + biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells. 2008; 26(6): 1464-1473.
38. Nelson TJ, Martinez-Fernandez A, Terzic A. KCNJ11 knockout morula reengineered by stem cell diploid aggregation. Phil Trans R Soc B. 2008; 364(1514): 269-276.
39. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Gottlinger HG. Functional association of cyclophilin A with HIV-1 virions. Nature. 1994; 372(6504): 363-365.
40. Chatterji U, Bobardt MD, Stanfield R, Ptak RG, Pallansch LA, Ward PA, Jones MJ, Stoddart CA, Scalfaro P, Dumont JM, Besseghir K, Rosenwirth B, Gallay PA. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and trim-cyclophilin resistant in owl monkey cells. J Biol Chem. 2005; 280(48): 40293-40300.
41. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-l). Proc Natl Acad Sci USA. 1978; 75(11): 5565-5569.
42. Damjanov I, Solter D. Animal model of human disease: Teratoma and teratocarcinoma. Am J Pathol. 1976; 83(1): 241-244.
43. Lensch MW, Schlaeger TM, Zon LI, Daley GQ. Teratoma formation assays with human embryonic stem cells: A rationale for one type of human-animal chimera. Cell Stem Cell. 2007; 1(3): 253-258.
44. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A, Terzic A. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells. 2008; 26(10): 2644-2653.
45. Wood SA, Allen ND, Rossant J, Auerbach A, Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature. 1993; 365(6441): 87-89.
46. Stewart C. Aggregation between teratocarcinoma cells and preimplantation mouse embryos. J Embryo! Exp Morphol. 1980; 58: 289-302.
47. Fujii JT, Martin GR. Incorporation of teratocarcinoma stem cells into blastocysts by aggregation with cleavage-stage embryos. DevBioi. 1980; 74(1): 239-244.
48. Waters BK, Rossant J. The effect of retinoic acid pretreatment on the ability of murine embryonal carcinoma and inner cell mass cells to participate in chimaera development. J Embryol Exp Morphol. 1986; 98: 99-110.
49. Nagy A, Gocza E, Diaz EM, Prideaux VR, Ivanyi E, Markkula M, Rossant J. Embryonic stem cells alone are able to support fetal development in the mouse. Development. 1990; 110(3): 815-821.
50. Hofmann W, Schubert D, LaBonte J, Munson L, Gibson S, Scammell J, Ferrigno P, Sodroski J. Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol. 1999; 73(12): 10020-10028.
51. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 2004; 427(6977): 848-853.
52. Zhang JX, Diehl GE, Littman DR. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS ONE. 2008; 3: E2035.
53. Noser JA, Towers GJ, Sakuma R, Dumont JM, Collins MK, Ikeda Y. Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. J Virol. 2006; 80(15): 7769-7774.
54. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells. 2002; 20(4): 329-337.